speb/financial-data huggingface dataset:
DX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -3471000.00
DX cash_flow (annual, 2024-12-31) — Changes In Cash: 383675000.00
DX balance_sheet (annual, 2024-12-31) — Common Stock: 845000.00
DX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1077093000.00
DX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 332317000.00
DX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1867000.00
DX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1867000.00
DX balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 22814000.00
DX income_statement (annual, 2024-12-31) — Diluted Average Shares: 71260358.00
DX income_statement (annual, 2024-12-31) — Diluted EPS: 1.49
DX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 106204000.00
DX balance_sheet (annual, 2024-12-31) — Dividends Payable: 16501000.00
DX cash_flow (annual, 2024-12-31) — End Cash Position: 621539000.00
DX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1395309000.00
DX cash_flow (annual, 2024-12-31) — Free Cash Flow: 14392000.00
DX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1506000.00
DX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 144519000.00
DX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -172489000.00
DX income_statement (annual, 2024-12-31) — General And Administrative Expense: 34593000.00
DX income_statement (annual, 2024-12-31) — Interest Expense: 313657000.00
DX income_statement (annual, 2024-12-31) — Interest Income: 319534000.00
DX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 322179000.00
DX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1026026000.00
DX balance_sheet (annual, 2024-12-31) — Investments And Advances: 618458000.00
DX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 332317000.00
DX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 332317000.00
DX income_statement (annual, 2024-12-31) — Net Income: 113898000.00
DX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 106204000.00
DX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 113898000.00
DX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 113898000.00
DX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 113898000.00
DX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 113898000.00
DX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 113898000.00
DX income_statement (annual, 2024-12-31) — Net Interest Income: 5877000.00
DX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -980787000.00
DX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1180000.00
DX cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -46001000.00
DX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1184936000.00
DX income_statement (annual, 2024-12-31) — Normalized Income: 113898000.00
DX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14392000.00
DX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -286872000.00
DX income_statement (annual, 2024-12-31) — Operating Revenue: 150396000.00
DX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 84491800.00
DX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -172489000.00
DX income_statement (annual, 2024-12-31) — Other Gand A: 14088000.00
DX income_statement (annual, 2024-12-31) — Other Non Interest Expense: 1905000.00
DX balance_sheet (annual, 2024-12-31) — Other Payable: 341924000.00
DX balance_sheet (annual, 2024-12-31) — Other Receivables: 10445000.00
DX balance_sheet (annual, 2024-12-31) — Payables: 403097000.00
DX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 403097000.00
DX balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 4460000.00
DX balance_sheet (annual, 2024-12-31) — Preferred Stock: 107843000.00
DX income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 7694000.00
DX balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 107843000.00
DX income_statement (annual, 2024-12-31) — Pretax Income: 113898000.00
DX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1872422000.00
DX balance_sheet (annual, 2024-12-31) — Receivables: 43286000.00
DX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1867000.00
DX balance_sheet (annual, 2024-12-31) — Retained Earnings: -493734000.00
DX income_statement (annual, 2024-12-31) — Salaries And Wages: 20505000.00
DX cash_flow (annual, 2024-12-31) — Sale Of Investment: 891635000.00
DX income_statement (annual, 2024-12-31) — Selling General And Administration: 34593000.00
DX balance_sheet (annual, 2024-12-31) — Share Issued: 84491800.00
DX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 7235000.00
DX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1184936000.00
DX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1077093000.00
DX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
DX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
DX balance_sheet (annual, 2024-12-31) — Total Assets: 8184579000.00
DX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1184936000.00
DX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 6999643000.00
DX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 142352000.00
DX income_statement (quarterly, 2025-03-31) — +Total Revenue: 9042000.00
DX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 46861000.00
DX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 36686000.00
DX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1982781000.00
DX balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 779309000.00
DX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 90492327.00
DX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.06
DX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 621539000.00
DX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 108865000.00
DX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 327447000.00
DX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 588010000.00
DX cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -41616000.00
DX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 868464000.00
DX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -908356000.00
DX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 6363000.00
DX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2189000.00
DX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -7482000.00
DX cash_flow (quarterly, 2025-03-31) — Change In Payable: 2189000.00
DX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2189000.00
DX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3845000.00
DX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -9138000.00
DX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3845000.00
DX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -33529000.00
DX balance_sheet (quarterly, 2025-03-31) — Common Stock: 1022000.00
DX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1288072000.00
DX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 239658000.00
DX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 496000.00
DX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 496000.00
DX balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 3810000.00
DX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 90492327.00
DX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.06
DX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4999000.00
DX balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 20707000.00
DX cash_flow (quarterly, 2025-03-31) — End Cash Position: 588010000.00
DX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 868464000.00
DX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 6363000.00
DX cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 0.00
DX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -8091000.00
DX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -153099000.00
DX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11764000.00
DX income_statement (quarterly, 2025-03-31) — Interest Expense: 77926000.00
DX income_statement (quarterly, 2025-03-31) — Interest Income: 95059000.00
DX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 75738000.00
DX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -908356000.00
DX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 779309000.00
DX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 239658000.00
DX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 239658000.00
DX income_statement (quarterly, 2025-03-31) — Net Income: -3076000.00
DX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -4999000.00
DX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3076000.00
DX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3076000.00
DX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3076000.00
DX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3076000.00
DX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3076000.00
DX income_statement (quarterly, 2025-03-31) — Net Interest Income: 17133000.00
DX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -913221000.00
DX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1181000.00
DX cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 4798000.00
DX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1395915000.00
DX income_statement (quarterly, 2025-03-31) — Normalized Income: -3076000.00
DX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 6363000.00
DX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 118088000.00
DX income_statement (quarterly, 2025-03-31) — Operating Revenue: 9042000.00
DX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 102226355.00
DX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -153099000.00
DX income_statement (quarterly, 2025-03-31) — Other Gand A: 3845000.00
DX income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 354000.00
DX balance_sheet (quarterly, 2025-03-31) — Other Payable: 332676000.00
DX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 2645000.00
DX balance_sheet (quarterly, 2025-03-31) — Payables: 400244000.00
DX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 400244000.00
DX balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 4460000.00
DX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 107843000.00
DX income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 1923000.00
DX balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 107843000.00
DX income_statement (quarterly, 2025-03-31) — Pretax Income: -3076000.00
DX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1094113000.00
DX balance_sheet (quarterly, 2025-03-31) — Receivables: 39331000.00
DX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 496000.00
DX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -542632000.00
DX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 7919000.00
DX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 180892000.00
DX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 11764000.00
DX balance_sheet (quarterly, 2025-03-31) — Share Issued: 102226355.00
DX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2029000.00
DX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1395915000.00
DX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1288072000.00
DX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
DX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
DX balance_sheet (quarterly, 2025-03-31) — Total Assets: 9044836000.00
DX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1395915000.00
DX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7648921000.00
DX cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -109997000.00
DX income_statement (quarterly, 2025-06-30) — +Total Revenue: -1313000.00
DX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 60855000.00
DX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 43309000.00
DX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2268143000.00
DX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 1443250000.00
DX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 113177331.00
DX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.14
DX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 588010000.00
DX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 109096000.00
DX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 387520000.00
DX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 705837000.00
DX cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -56555000.00
DX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1591014000.00
DX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1505066000.00
DX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 31879000.00
DX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 13994000.00
DX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 3270000.00
DX cash_flow (quarterly, 2025-06-30) — Change In Payable: 13994000.00
DX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 13994000.00
DX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -6623000.00
DX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 10641000.00
DX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -6623000.00
DX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 117827000.00
DX balance_sheet (quarterly, 2025-06-30) — Common Stock: 1253000.00
DX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1502150000.00
DX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 282149000.00
DX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 516000.00
DX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 516000.00
DX balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 31000.00
DX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 113177331.00
DX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.14
DX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -16286000.00
DX balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 26125000.00
DX cash_flow (quarterly, 2025-06-30) — End Cash Position: 705837000.00
DX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1591014000.00
DX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 31879000.00
DX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
DX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -24441000.00
DX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -149035000.00
DX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 11913000.00
DX income_statement (quarterly, 2025-06-30) — Interest Expense: 88618000.00
DX income_statement (quarterly, 2025-06-30) — Interest Income: 111746000.00
DX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 74624000.00
DX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1505066000.00
DX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1443250000.00
DX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 282149000.00
DX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 282149000.00
DX income_statement (quarterly, 2025-06-30) — Net Income: -13606000.00
DX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -16286000.00
DX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -13606000.00
DX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -13606000.00
DX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -13606000.00
DX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -13606000.00
DX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -13606000.00
DX income_statement (quarterly, 2025-06-30) — Net Interest Income: 23128000.00
DX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -1529648000.00
DX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
DX cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 24525000.00
DX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1609993000.00
DX income_statement (quarterly, 2025-06-30) — Normalized Income: -13606000.00
DX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 31879000.00
DX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 58093000.00
DX income_statement (quarterly, 2025-06-30) — Operating Revenue: -1313000.00
DX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 125358375.00
DX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -149035000.00
DX income_statement (quarterly, 2025-06-30) — Other Gand A: 3900000.00
DX income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 380000.00
DX balance_sheet (quarterly, 2025-06-30) — Other Payable: 976506000.00
DX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 12349000.00
DX balance_sheet (quarterly, 2025-06-30) — Payables: 1063486000.00
DX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1063486000.00
DX balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 4460000.00
DX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 107843000.00
DX income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 2680000.00
DX balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 107843000.00
DX income_statement (quarterly, 2025-06-30) — Pretax Income: -13606000.00
DX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1736514000.00
DX balance_sheet (quarterly, 2025-06-30) — Receivables: 55658000.00
DX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 516000.00
DX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -618211000.00
DX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 8013000.00
DX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 206866000.00
DX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 11913000.00
DX balance_sheet (quarterly, 2025-06-30) — Share Issued: 125358375.00
DX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3486000.00
DX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1609993000.00
DX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1502150000.00
DX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
DX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
DX balance_sheet (quarterly, 2025-06-30) — Total Assets: 11311265000.00
DX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1609993000.00
DX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9701272000.00
DX cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -33652000.00
DX income_statement (quarterly, 2025-09-30) — +Total Revenue: 162386000.00
DX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 110517000.00
DX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 55931000.00
DX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2524286000.00
DX balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 847534000.00
DX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 135952339.00
DX income_statement (quarterly, 2025-09-30) — Basic EPS: 1.09
DX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 705837000.00
DX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 109300000.00
DX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 490989000.00
DX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 823807000.00
DX cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -69584000.00
DX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 3337336000.00
DX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3287641000.00
DX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 68275000.00
DX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 49662000.00
DX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 3267000.00
DX cash_flow (quarterly, 2025-09-30) — Change In Payable: 49662000.00
DX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 49662000.00
DX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -12622000.00
DX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 40307000.00
DX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -12622000.00
DX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 117970000.00
DX balance_sheet (quarterly, 2025-09-30) — Common Stock: 1457000.00
DX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1849705000.00
DX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 254139000.00
DX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 544000.00
DX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 544000.00
DX balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 4635000.00
DX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 136927985.00
DX income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.08
DX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 147561000.00
DX balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 30688000.00
DX cash_flow (quarterly, 2025-09-30) — End Cash Position: 823807000.00
DX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 3337336000.00
DX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 68275000.00
DX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
DX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 131775000.00
DX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -134069000.00
DX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 11464000.00
DX income_statement (quarterly, 2025-09-30) — Interest Expense: 119068000.00
DX income_statement (quarterly, 2025-09-30) — Interest Income: 149679000.00
DX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 69406000.00
DX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3287641000.00
DX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 847534000.00
DX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 254139000.00
DX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 254139000.00
DX income_statement (quarterly, 2025-09-30) — Net Income: 150388000.00
DX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 147561000.00
DX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 150388000.00
DX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 150388000.00
DX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 150388000.00
DX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 150389000.00
DX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 150388000.00
DX income_statement (quarterly, 2025-09-30) — Net Interest Income: 30611000.00
DX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -3276834000.00
DX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -598000.00
DX cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -10899000.00
DX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1957548000.00
DX income_statement (quarterly, 2025-09-30) — Normalized Income: 150388000.00
DX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 68275000.00
DX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 10694000.00
DX income_statement (quarterly, 2025-09-30) — Operating Revenue: 162386000.00
DX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 145714136.00
DX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -134069000.00
DX income_statement (quarterly, 2025-09-30) — Other Gand A: 4139000.00
DX income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 534000.00
DX balance_sheet (quarterly, 2025-09-30) — Other Payable: 270719000.00
DX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 25255000.00
DX balance_sheet (quarterly, 2025-09-30) — Payables: 411924000.00
DX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 411924000.00
DX balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 4460000.00
DX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 107843000.00
DX income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 2827000.00
DX balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 107843000.00
DX income_statement (quarterly, 2025-09-30) — Pretax Income: 150388000.00
DX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3533259000.00
DX balance_sheet (quarterly, 2025-09-30) — Receivables: 81186000.00
DX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 544000.00
DX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -541969000.00
DX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 7325000.00
DX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 256425000.00
DX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 11464000.00
DX balance_sheet (quarterly, 2025-09-30) — Share Issued: 145714136.00
DX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2801000.00
DX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1957548000.00
DX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1849705000.00
DX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
DX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
DX balance_sheet (quarterly, 2025-09-30) — Total Assets: 14158694000.00
DX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1957548000.00
DX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 12201146000.00
DX cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -142469000.00
DX income_statement (annual, 2025-12-31) — +Total Revenue: 372113000.00
DX income_statement (quarterly, 2025-12-31) — +Total Revenue: 201998000.00
DX balance_sheet (annual, 2025-12-31) — Accounts Payable: 95196000.00
DX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 95196000.00
DX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 67940000.00
DX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 67940000.00
DX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2921551000.00
DX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2921551000.00
DX balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 1713518000.00
DX balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1713518000.00
DX income_statement (annual, 2025-12-31) — Basic Average Shares: 124128422.00
DX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 156041438.00
DX income_statement (annual, 2025-12-31) — Basic EPS: 2.49
DX income_statement (quarterly, 2025-12-31) — Basic EPS: 1.17
DX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 621539000.00
DX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 823807000.00
DX balance_sheet (annual, 2025-12-31) — Capital Stock: 109591000.00
DX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 109591000.00
DX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 531043000.00
DX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 531043000.00
DX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 930387000.00
DX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 930387000.00
DX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -246599000.00
DX cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -78844000.00
DX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8262004000.00
DX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2465190000.00
DX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8073977000.00
DX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2372914000.00
DX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 120821000.00
DX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 14304000.00
DX cash_flow (annual, 2025-12-31) — Change In Account Payable: 50524000.00
DX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -15321000.00
DX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 3457000.00
DX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 4402000.00
DX cash_flow (annual, 2025-12-31) — Change In Payable: 50524000.00
DX cash_flow (quarterly, 2025-12-31) — Change In Payable: -15321000.00
DX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 50524000.00
DX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -15321000.00
DX cash_flow (annual, 2025-12-31) — Change In Receivables: -35099000.00
DX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -12009000.00
DX cash_flow (annual, 2025-12-31) — Change In Working Capital: 18882000.00
DX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -22928000.00
DX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -35099000.00
DX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -12009000.00
DX cash_flow (annual, 2025-12-31) — Changes In Cash: 308848000.00
DX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 106580000.00
DX balance_sheet (annual, 2025-12-31) — Common Stock: 1748000.00
DX balance_sheet (quarterly, 2025-12-31) — Common Stock: 1748000.00
DX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2354301000.00
DX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2354301000.00
DX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1169278000.00
DX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 393332000.00
DX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2098000.00
DX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 542000.00
DX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2098000.00
DX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 542000.00
DX balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 4830000.00
DX balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 4830000.00
DX income_statement (annual, 2025-12-31) — Diluted Average Shares: 125067280.00
DX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 157213691.00
DX income_statement (annual, 2025-12-31) — Diluted EPS: 2.47
DX income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.16
DX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 308875000.00
DX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 182599000.00
DX balance_sheet (annual, 2025-12-31) — Dividends Payable: 37171000.00
DX balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 37171000.00
DX cash_flow (annual, 2025-12-31) — End Cash Position: 930387000.00
DX cash_flow (quarterly, 2025-12-31) — End Cash Position: 930387000.00
DX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 8262004000.00
DX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2465190000.00
DX cash_flow (annual, 2025-12-31) — Free Cash Flow: 120821000.00
DX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 14304000.00
DX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 0.00
DX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
DX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 257757000.00
DX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 158514000.00
DX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -127061000.00
DX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -127061000.00
DX income_statement (annual, 2025-12-31) — General And Administrative Expense: 51508000.00
DX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 16368000.00
DX income_statement (annual, 2025-12-31) — Interest Expense: 419165000.00
DX income_statement (quarterly, 2025-12-31) — Interest Expense: 133553000.00
DX income_statement (annual, 2025-12-31) — Interest Income: 533521000.00
DX income_statement (quarterly, 2025-12-31) — Interest Income: 177037000.00
DX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 368641000.00
DX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 148873000.00
DX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -8073977000.00
DX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2372914000.00
DX balance_sheet (annual, 2025-12-31) — Investments And Advances: 1713518000.00
DX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1713518000.00
DX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1169278000.00
DX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 393332000.00
DX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1169278000.00
DX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 393332000.00
DX income_statement (annual, 2025-12-31) — Net Income: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Net Income: 185359000.00
DX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 308875000.00
DX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 182599000.00
DX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 185359000.00
DX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 185359000.00
DX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 185359000.00
DX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 319066000.00
DX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 185359000.00
DX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 185359000.00
DX income_statement (annual, 2025-12-31) — Net Interest Income: 114356000.00
DX income_statement (quarterly, 2025-12-31) — Net Interest Income: 43484000.00
DX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -8082899000.00
DX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -2363196000.00
DX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1786000.00
DX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -7000.00
DX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 8373000.00
DX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -10051000.00
DX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2462144000.00
DX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2462144000.00
DX income_statement (annual, 2025-12-31) — Normalized Income: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Normalized Income: 185359000.00
DX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 120821000.00
DX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 14304000.00
DX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 113093000.00
DX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -73782000.00
DX income_statement (annual, 2025-12-31) — Operating Revenue: 372113000.00
DX income_statement (quarterly, 2025-12-31) — Operating Revenue: 201998000.00
DX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 174814912.00
DX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 174814912.00
DX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -127061000.00
DX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -127061000.00
DX income_statement (annual, 2025-12-31) — Other Gand A: 16381000.00
DX income_statement (quarterly, 2025-12-31) — Other Gand A: 4497000.00
DX income_statement (annual, 2025-12-31) — Other Non Interest Expense: 1539000.00
DX income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 271000.00
DX balance_sheet (annual, 2025-12-31) — Other Payable: 811656000.00
DX balance_sheet (quarterly, 2025-12-31) — Other Payable: 811656000.00
DX balance_sheet (annual, 2025-12-31) — Other Receivables: 17425000.00
DX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 17425000.00
DX balance_sheet (annual, 2025-12-31) — Payables: 944023000.00
DX balance_sheet (quarterly, 2025-12-31) — Payables: 944023000.00
DX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 944023000.00
DX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 944023000.00
DX balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 4460000.00
DX balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 4460000.00
DX balance_sheet (annual, 2025-12-31) — Preferred Stock: 107843000.00
DX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 107843000.00
DX income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 10191000.00
DX income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2760000.00
DX balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 107843000.00
DX balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 107843000.00
DX income_statement (annual, 2025-12-31) — Pretax Income: 319066000.00
DX income_statement (quarterly, 2025-12-31) — Pretax Income: 185359000.00
DX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -9035622000.00
DX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -2671736000.00
DX balance_sheet (annual, 2025-12-31) — Receivables: 85365000.00
DX balance_sheet (quarterly, 2025-12-31) — Receivables: 85365000.00
DX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2098000.00
DX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 542000.00
DX balance_sheet (annual, 2025-12-31) — Retained Earnings: -441937000.00
DX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -441937000.00
DX income_statement (annual, 2025-12-31) — Salaries And Wages: 35127000.00
DX income_statement (quarterly, 2025-12-31) — Salaries And Wages: 11871000.00
DX cash_flow (annual, 2025-12-31) — Sale Of Investment: 952723000.00
DX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 308540000.00
DX income_statement (annual, 2025-12-31) — Selling General And Administration: 51508000.00
DX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 16368000.00
DX balance_sheet (annual, 2025-12-31) — Share Issued: 174814912.00
DX balance_sheet (quarterly, 2025-12-31) — Share Issued: 174814912.00
DX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 12565000.00
DX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4249000.00
DX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2462144000.00
DX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2462144000.00
DX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2354301000.00
DX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2354301000.00
DX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
DX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
DX balance_sheet (annual, 2025-12-31) — Total Assets: 17342178000.00
DX balance_sheet (quarterly, 2025-12-31) — Total Assets: 17342178000.00
DX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2462144000.00
DX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2462144000.00
DX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14880034000.00
DX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14880034000.00
DX cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -370850000.00
DX cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -84732000.00
DX income_statement (quarterly, 2026-03-31) — +Total Revenue: -59109000.00
DX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 131426000.00
DX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 97454000.00
DX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3368130000.00
DX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 822925000.00
DX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 200084349.00
DX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.41
DX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 930387000.00
DX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 109915000.00
DX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 773138000.00
DX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1289640000.00
DX cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -102545000.00
DX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 7477937000.00
DX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -7188533000.00
DX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 69849000.00
DX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 36230000.00
DX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -9030000.00
DX cash_flow (quarterly, 2026-03-31) — Change In Payable: 36230000.00
DX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 36230000.00
DX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -29514000.00
DX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2314000.00
DX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -29514000.00
DX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 359253000.00
DX balance_sheet (quarterly, 2026-03-31) — Common Stock: 2072000.00
DX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2613427000.00
DX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 441743000.00
DX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 545000.00
DX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 545000.00
DX balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 14121000.00
DX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 200084349.00
DX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.41
DX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -83020000.00
DX balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 41893000.00
DX cash_flow (quarterly, 2026-03-31) — End Cash Position: 1289640000.00
DX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 7477937000.00
DX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 69849000.00
DX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -8721000.00
DX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -138363000.00
DX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -127209000.00
DX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 20478000.00
DX income_statement (quarterly, 2026-03-31) — Interest Expense: 178136000.00
DX income_statement (quarterly, 2026-03-31) — Interest Income: 257390000.00
DX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 141905000.00
DX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -7188533000.00
DX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 822925000.00
DX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 441743000.00
DX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 441743000.00
DX income_statement (quarterly, 2026-03-31) — Net Income: -80362000.00
DX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -83020000.00
DX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -80362000.00
DX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -80362000.00
DX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -80362000.00
DX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -80362000.00
DX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -80362000.00
DX income_statement (quarterly, 2026-03-31) — Net Interest Income: 79254000.00
DX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -7180177000.00
DX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -2487000.00
DX cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -8373000.00
DX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2721270000.00
DX income_statement (quarterly, 2026-03-31) — Normalized Income: -80362000.00
DX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 69849000.00
DX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -113448000.00
DX income_statement (quarterly, 2026-03-31) — Operating Revenue: -59109000.00
DX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 207154465.00
DX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -127209000.00
DX income_statement (quarterly, 2026-03-31) — Other Gand A: 5169000.00
DX income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 775000.00
DX balance_sheet (quarterly, 2026-03-31) — Other Payable: 379893000.00
DX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 3434000.00
DX balance_sheet (quarterly, 2026-03-31) — Payables: 553212000.00
DX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 553212000.00
DX balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 4460000.00